Assenagon Asset Management S.A. Harvard Bioscience Inc Transaction History
Assenagon Asset Management S.A.
- $54.8 Billion
- Q1 2025
A detailed history of Assenagon Asset Management S.A. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 54,426 shares of HBIO stock, worth $28,845. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,426
Previous 69,799
22.02%
Holding current value
$28,845
Previous $147,000
78.91%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
26.2MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.39MShares$1.8 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.51 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$1.16 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$1.13 Million0.0% of portfolio
-
Royce & Associates LP1.78MShares$942,2830.01% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $22.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...